Company positioned for long-term sustainable growth following the acquisition of Yourgene Health Paris, France and Eastleigh, UK – 28 September 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international...

Paris, France, and Eastleigh UK – 14 September 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that shareholders are now able to...

Paris, France and Eastleigh, UK – 29 August 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting...

Paris, France and Eastleigh, UK – 17 August 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, notes today’s announcement by Yourgene Health plc (“Yourgene”),...

Non-COVID sales growing quarter-on-quarter, significant progress in product development and non-organic growth strategy Paris, France and Eastleigh, UK – 27 July 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international...

Paris, France and Eastleigh, UK – 13 July 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting (AGM),...